13F

GRAL GRAIL INC

2026Q1 · CUSIP 384747101 · Sector: Healthcare & Biotech

Danger · Dual-confirm: breadth + price
Holders
364
Δ holders QoQ
-59
Breadth percentile
Top 98%
Whale holders
149
Δ whales
-12
Inst. holding value
$1.8B
New positions
49
Closed positions
108
Price momentum (1Q)
-38.7%
Put / Call
8/12

Breadth history (34 quarters)

2024Q2: Δ+368 · h=370 2024Q3: Δ-57 · h=313 2024Q4: Δ+22 · h=335 2025Q1: Δ-19 · h=316 2025Q2: Δ+32 · h=348 2025Q3: Δ+2 · h=350 2025Q4: Δ+73 · h=423 2026Q1: Δ-59 · h=364 2024Q2: holders=370 2024Q3: holders=313 2024Q4: holders=335 2025Q1: holders=316 2025Q2: holders=348 2025Q3: holders=350 2025Q4: holders=423 2026Q1: holders=364 -368 -184 +0 +184 +368 281363445 24Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 6% -38.7%
2025Q2 Top 9% +142.8% +211.8%
2024Q2 Top 0% -5.6% +214.0%

Options Sentiment

Put holders
8
QoQ: 0
Call holders
12
QoQ: -1

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-10.30
EPS YoY
Revenue (TTM)
$0.2B
Revenue YoY
+19.4%
Quarterly Revenue & EPS (4Y)
2023-06-30: $22M 2023-10-01: $21M 2024-03-31: $27M 2024-06-30: $32M 2024-09-30: $29M 2024-12-31: $38M 2025-03-31: $32M 2025-06-30: $36M 2025-09-30: $36M 2025-12-31: $44M 2026-03-31: $41M 2023-06-30: EPS -6.22 2023-10-01: EPS -28.71 2024-03-31: EPS -7.05 2024-06-30: EPS -51.06 2024-09-30: EPS -3.94 2024-12-31: EPS -1.49 2025-03-31: EPS -3.10 2025-06-30: EPS -3.18 2025-09-30: EPS -2.46 2025-12-31: EPS -2.37 2026-03-31: EPS -2.29 0M 22M 44M $M -56.17 -28.08 0.00 2023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)